Helicobacter pylori infection causes chronic gastritis, which can progress to severe
gastroduodenal pathologies, including peptic ulcer, gastric cancer and gastric mucosa …

Abstract Treatment for the eradication of Helicobacter pylori infection, a leading cause of
peptic ulcer disease and an important risk factor for gastric cancer and mucosa-associated …

This study presents a novel derivatization-free spectrofluorimetric method for the
quantification of vonoprazan (VPZ) that is characterized by its high sensitivity, environmental …

Potassium-competitive acid blockers (PCABs) such as vonoprazan represent a novel class
of acid suppressants that show tremendous promise to enhance care of acid peptic …

Helicobacter pylori (H. pylori)(formerly known as Campylobacter pyloridis) has been studied
for over a century due to its association with peptic ulcer disease and gastric cancer. Its …

ABSTRACT Background The efficacy of Helicobacter pylori (H. pylori) eradication therapies
encompassing one or more antibiotics and a proton pump inhibitor (PPI) has lately …

Helicobacter pylori has a big sway when peptic ulcers are concerned. For its eradication,
different protocols have been approved. Among which, the tripartite therapy protocol which …

Background: Helicobacter pylori eradication rates achieved with clarithromycin-based triple
therapies are declining due to antibiotic resistance, but data regarding temporal changes in …

Background: Japanese guidelines recommend triple therapy with vonoprazan or a proton
pump inhibitor (PPI) in combination with antibiotics to treat Helicobacter pylori (H. pylori) …

Helicobacter pylori is a prevalent, global infectious disease that causes dyspepsia, peptic
ulcer disease, and gastric cancer. The American College of Gastroenterology commissioned …